Paul Sherman serves as an executive at Billi, overseeing strategic initiatives and leadership responsibilities.
| Company | Designation | Period |
|---|---|---|
| Nylex | Group Financial Controller | Sep 2007 – Feb 2008 |
| Palla Pharma Limited | Chief Financial Officer | Oct 2021 – Apr 2023 |
| Clover Corporation | CFO | May 2016 – May 2021 |
| Menora Foods | CFO | May 2013 – May 2016 |
| Horizon Science Pty Ltd | CFO | Mar 2009 – May 2013 |
| Nylex | Group Financial Controller | Jan 2007 – Jan 2009 |
| Fosters Group | GM Finance | Jan 1998 – Jan 2007 |
| Fosters Group | GM Finance Clubs & Services | Aug 1998 – Aug 2007 |
| Midas Healthcare Ltd | Chief Financial Officer | Apr 2023 – Oct 2023 |
| Billi | Chief Financial Officer | Jan 2024 – Present |
Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Official Email: Via Billi corporate communication desk.
Personal Contact: Not publicly disclosed.
What is Paul Sherman's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them?
Through Billi's official communication channels.
Is this an official profile?
No — independently created using public data.
This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)